1. Home
  2. CZNC vs CUVL Comparison

CZNC vs CUVL Comparison

Compare CZNC & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens & Northern Corp

CZNC

Citizens & Northern Corp

HOLD

Current Price

$27.61

Market Cap

465.4M

Sector

Finance

ML Signal

HOLD

Logo Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$5.00

Market Cap

374.2M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
CZNC
CUVL
Founded
1864
1999
Country
United States
Australia
Employees
N/A
16
Industry
Major Banks
Miscellaneous
Sector
Finance
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
465.4M
374.2M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CZNC
CUVL
Price
$27.61
$5.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 46.6K
5.5K
Earning Date
11-03-2026
08-27-2026
Dividend Yield
★ 4.20%
0.57%
EPS Growth
N/A
N/A
EPS
★ 0.81
N/A
Revenue
N/A
N/A
Revenue This Year
$38.42
$0.89
Revenue Next Year
$4.97
$6.69
P/E Ratio
$32.90
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.87
$4.91
52 Week High
$26.73
$8.20

Technical Indicators

Market Signals
Indicator
CZNC
CUVL
Relative Strength Index (RSI) 76.41 29.90
Support Level $25.09 $4.91
Resistance Level N/A $6.04
Average True Range (ATR) 0.62 0.15
MACD 0.22 -0.02
Stochastic Oscillator 100.00 7.29

Price Performance

Historical Comparison
CZNC
CUVL

About CZNC Citizens & Northern Corp

Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.

About CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Share on Social Networks: